Latest Share Purchase Plan News

Page 16 of 97
Atomo Diagnostics lifted revenue 41% to AUD 5.33 million for FY26, cutting its loss by 29% to AUD 3.51 million, driven by HIV self-testing growth and a key US partnership. Leadership changes signal a strategic pivot as the company eyes global expansion.
Ada Torres
Ada Torres
31 Aug 2026
CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.
Ada Torres
Ada Torres
31 Aug 2026
Staude Capital Global Value Fund Limited posted a 47% drop in net profit after tax for FY2026 amid a 39% revenue decline, while adjusted pre-tax NTA rose 7%. The company declared a fully franked final dividend of 3.3 cents per share and completed a $18.2 million share purchase plan last year.
Claire Turing
Claire Turing
28 Aug 2026
Argo Global Listed Infrastructure Limited has renewed its on-market buy-back facility for another year, allowing up to 9.4 million shares to be repurchased as part of ongoing capital management.
Victor Sage
Victor Sage
28 Aug 2026
Austral Resources Australia Ltd has swung from a $24.2 million loss to a $25.3 million profit in the first half of 2026, boosted by strategic acquisitions, capital raises, and operational shifts. The company is advancing its Rocklands restart and has proposed acquiring Hammer Metals to expand its copper footprint.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Paradigm Biopharmaceuticals has surpassed its Phase 3 enrolment target for Zilosul®, secured over A$21 million in capital, and pivots towards clinical evidence generation with major data readouts expected.
Ada Torres
Ada Torres
28 Aug 2026
Bio-Gene Technology narrowed its loss to $2.33 million in FY26 while progressing key toxicity studies for Flavocide and securing a commercial foothold for Qcide in Japan. The company bolstered its balance sheet with a $3.275 million capital raise to fund ongoing development and production scale-up.
Ada Torres
Ada Torres
28 Aug 2026
CurveBeam AI has secured nearly half of its A$5 million placement at $0.02 per share, issuing 120 million shares to key investors while awaiting the remainder of funds from Intellivision Holdings.
Ada Torres
Ada Torres
28 Aug 2026
Saturn Metals has significantly oversubscribed its Share Purchase Plan, raising $21.28 million against a $5 million target. Combined with a recent $100 million placement, the company now has $121.28 million to accelerate development of its Apollo Hill Gold Project in Western Australia.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Weebit Nano surged to record revenue of $15.3 million in FY26, fueled by key licensing deals and product tape-outs, while investing heavily in R&D and AI initiatives. Despite a $54.9 million loss, a $102 million capital raise leaves the company well-positioned for growth.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Argo Global Listed Infrastructure (ASX: ALI) reported a robust FY2026 with total assets rising to $529 million and a record fully franked dividend of 10 cents per share. The portfolio outperformed benchmarks, driven by strong gains in electric utilities and midstream energy sectors amid AI-driven data centre demand.
Claire Turing
Claire Turing
27 Aug 2026
Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.
Ada Torres
Ada Torres
27 Aug 2026

Browse the archive

Full archive